Skip to main content

Table 2 DHODH inhibitors currently evaluated in clinical trials

From: DHODH and cancer: promising prospects to be explored

Drug

Clinical trial

Disease

Clinical trial identifier

Study start date

Brequinar

Phase I/II

Acute myeloid leukemia

NCT03760666

November 26, 2018

Leflunomide

Phase I/II

Multiple myeloma

NCT02509052

November 2, 2015

Teriflunomide

Phase IV

Multiple sclerosis

NCT01970410

October 2013

ASLAN003

Phase II

Acute myeloid leukemia

NCT03451084

January 5, 2018

BAY2402234

Phase I

Leukemia

NCT03404726

March 29, 2018

IMU-838

Phase II

Ulcerative colitis

NCT03341962

March 15, 2018

PTC299

Phase I

Acute myeloid leukemia

NCT03761069

October 29,2018